Europe Antidiabetics Market Report 2017

Europe Antidiabetics Market Report 2017

1 Antidiabetics Overview

1.1 Product Overview and Scope of Antidiabetics

1.2 Classification of Antidiabetics

1.2.1 Biguanides

1.2.2 Thiazolodinediones

1.2.3 GLP-agonists

1.2.4 Sulphonylureas

1.2.5 DPP-4 inhibitors

1.2.6 SGLT-2

1.2.7 Alpha-glucosidase Inhibitors

1.2.8 Meglitinides

1.3 Application of Antidiabetics

1.3.1 Hospitals & Clinics

1.3.2 Retail pharmacies

1.3.3 Online sales

1.4 Antidiabetics Market by Countries

1.4.1 Germany Status and Prospect (2011-2021)

1.4.2 France Status and Prospect (2011-2021)

1.4.3 UK Status and Prospect (2011-2021)

1.4.4 Russia Status and Prospect (2011-2021)

1.4.5 Italy Status and Prospect (2011-2021)

1.4.6 Spain Status and Prospect (2011-2021)

1.4.7 Benelux Status and Prospect (2011-2021)

1.5 Europe Market Size (Value and Volume) of Antidiabetics (2011-2021)

1.5.1 Europe Antidiabetics Sales and Growth Rate (2011-2021)

1.5.2 Europe Antidiabetics Revenue and Growth Rate (2011-2021)

2 Europe Antidiabetics by Manufacturers, Type and Application

2.1 Europe Antidiabetics Market Competition by Manufacturers

2.1.1 Europe Antidiabetics Sales and Market Share of Key Manufacturers (2015 and 2016)

2.1.2 Europe Antidiabetics Revenue and Share by Manufacturers (2015 and 2016)

2.2 Europe Antidiabetics (Volume and Value) by Type

2.2.1 Europe Antidiabetics Sales and Market Share by Type (2011-2016)

2.2.2 Europe Antidiabetics Revenue and Market Share by Type (2011-2016)

2.3 Europe Antidiabetics (Volume and Value) by Countries

2.3.1 Europe Antidiabetics Sales and Market Share by Countries (2011-2016)

2.3.2 Europe Antidiabetics Revenue and Market Share by Countries (2011-2016)

2.4 Europe Antidiabetics (Volume) by Application

3 Germany Antidiabetics (Volume, Value and Sales Price)

3.1 Germany Antidiabetics Sales and Value (2011-2016)

3.1.1 Germany Antidiabetics Sales and Growth Rate (2011-2016)

3.1.2 Germany Antidiabetics Revenue and Growth Rate (2011-2016)

3.1.3 Germany Antidiabetics Sales Price Trend (2011-2016)

3.2 Germany Antidiabetics Sales and Market Share by Manufacturers

3.3 Germany Antidiabetics Sales and Market Share by Type

3.4 Germany Antidiabetics Sales and Market Share by Application

4 France Antidiabetics (Volume, Value and Sales Price)

4.1 France Antidiabetics Sales and Value (2011-2016)

4.1.1 France Antidiabetics Sales and Growth Rate (2011-2016)

4.1.2 France Antidiabetics Revenue and Growth Rate (2011-2016)

4.1.4 France Antidiabetics Sales Price Trend (2011-2016)

4.2 France Antidiabetics Sales and Market Share by Manufacturers

4.3 France Antidiabetics Sales and Market Share by Type

4.4 France Antidiabetics Sales and Market Share by Application

5 UK Antidiabetics (Volume, Value and Sales Price)

5.1 UK Antidiabetics Sales and Value (2011-2016)

5.1.1 UK Antidiabetics Sales and Growth Rate (2011-2016)

5.1.2 UK Antidiabetics Revenue and Growth Rate (2011-2016)

5.1.5 UK Antidiabetics Sales Price Trend (2011-2016)

5.2 UK Antidiabetics Sales and Market Share by Manufacturers

5.3 UK Antidiabetics Sales and Market Share by Type

5.4 UK Antidiabetics Sales and Market Share by Application

6 Russia Antidiabetics (Volume, Value and Sales Price)

6.1 Russia Antidiabetics Sales and Value (2011-2016)

6.1.1 Russia Antidiabetics Sales and Growth Rate (2011-2016)

6.1.2 Russia Antidiabetics Revenue and Growth Rate (2011-2016)

6.1.6 Russia Antidiabetics Sales Price Trend (2011-2016)

6.2 Russia Antidiabetics Sales and Market Share by Manufacturers

6.3 Russia Antidiabetics Sales and Market Share by Type

6.4 Russia Antidiabetics Sales and Market Share by Application

7 Italy Antidiabetics (Volume, Value and Sales Price)

7.1 Italy Antidiabetics Sales and Value (2011-2016)

7.1.1 Italy Antidiabetics Sales and Growth Rate (2011-2016)

7.1.2 Italy Antidiabetics Revenue and Growth Rate (2011-2016)

7.1.7 Italy Antidiabetics Sales Price Trend (2011-2016)

7.2 Italy Antidiabetics Sales and Market Share by Manufacturers

7.3 Italy Antidiabetics Sales and Market Share by Type

7.4 Italy Antidiabetics Sales and Market Share by Application

8 Spain Antidiabetics (Volume, Value and Sales Price)

8.1 Spain Antidiabetics Sales and Value (2011-2016)

8.1.1 Spain Antidiabetics Sales and Growth Rate (2011-2016)

8.1.2 Spain Antidiabetics Revenue and Growth Rate (2011-2016)

8.1.8 Spain Antidiabetics Sales Price Trend (2011-2016)

8.2 Spain Antidiabetics Sales and Market Share by Manufacturers

8.3 Spain Antidiabetics Sales and Market Share by Type

8.4 Spain Antidiabetics Sales and Market Share by Application

9 Benelux Antidiabetics (Volume, Value and Sales Price)

9.1 Benelux Antidiabetics Sales and Value (2011-2016)

9.1.1 Benelux Antidiabetics Sales and Growth Rate (2011-2016)

9.1.2 Benelux Antidiabetics Revenue and Growth Rate (2011-2016)

9.1.9 Benelux Antidiabetics Sales Price Trend (2011-2016)

9.2 Benelux Antidiabetics Sales and Market Share by Manufacturers

9.3 Benelux Antidiabetics Sales and Market Share by Type

9.4 Benelux Antidiabetics Sales and Market Share by Application

10 Europe Antidiabetics Manufacturers Analysis

10.1 Sanofi-Aventis

10.1.1 Company Basic Information, Manufacturing Base and Competitors

10.1.2 Antidiabetics Product Type, Application and Specification

10.1.2.1 Biguanides

10.1.2.2 Thiazolodinediones

10.1.3 Sanofi-Aventis Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)

10.1.4 Main Business/Business Overview

10.2 Eli Lilly

10.2.1 Company Basic Information, Manufacturing Base and Competitors

10.2.2 Antidiabetics Product Type, Application and Specification

10.2.2.1 Biguanides

10.2.2.2 Thiazolodinediones

10.2.3 Eli Lilly Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)

10.2.4 Main Business/Business Overview

10.3 Oramed Pharmaceuticals

10.3.1 Company Basic Information, Manufacturing Base and Competitors

10.3.2 Antidiabetics Product Type, Application and Specification

10.3.2.1 Biguanides

10.3.2.2 Thiazolodinediones

10.3.3 Oramed Pharmaceuticals Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)

10.3.4 Main Business/Business Overview

10.4 Boehringer Ingelheim

10.4.1 Company Basic Information, Manufacturing Base and Competitors

10.4.2 Antidiabetics Product Type, Application and Specification

10.4.2.1 Biguanides

10.4.2.2 Thiazolodinediones

10.4.3 Boehringer Ingelheim Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)

10.4.4 Main Business/Business Overview

10.5 Merck & Co. Inc

10.5.1 Company Basic Information, Manufacturing Base and Competitors

10.5.2 Antidiabetics Product Type, Application and Specification

10.5.2.1 Biguanides

10.5.2.2 Thiazolodinediones

10.5.3 Merck & Co. Inc Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)

10.5.4 Main Business/Business Overview

10.6 Bristol-Myers Squibb

10.6.1 Company Basic Information, Manufacturing Base and Competitors

10.6.2 Antidiabetics Product Type, Application and Specification

10.6.2.1 Biguanides

10.6.2.2 Thiazolodinediones

10.6.3 Bristol-Myers Squibb Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)

10.6.4 Main Business/Business Overview

10.7 Novo Nordisk

10.7.1 Company Basic Information, Manufacturing Base and Competitors

10.7.2 Antidiabetics Product Type, Application and Specification

10.7.2.1 Biguanides

10.7.2.2 Thiazolodinediones

10.7.3 Novo Nordisk Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)

10.7.4 Main Business/Business Overview

10.8 Halozyme Therapeutics

10.8.1 Company Basic Information, Manufacturing Base and Competitors

10.8.2 Antidiabetics Product Type, Application and Specification

10.8.2.1 Biguanides

10.8.2.2 Thiazolodinediones

10.8.3 Halozyme Therapeutics Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)

10.8.4 Main Business/Business Overview

10.9 Pfizer

10.9.1 Company Basic Information, Manufacturing Base and Competitors

10.9.2 Antidiabetics Product Type, Application and Specification

10.9.2.1 Biguanides

10.9.2.2 Thiazolodinediones

10.9.3 Pfizer Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)

10.9.4 Main Business/Business Overview

10.10 Takeda Pharmaceuticals

10.10.1 Company Basic Information, Manufacturing Base and Competitors

10.10.2 Antidiabetics Product Type, Application and Specification

10.10.2.1 Biguanides

10.10.2.2 Thiazolodinediones

10.10.3 Takeda Pharmaceuticals Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)

10.10.4 Main Business/Business Overview

10.11 Nanjing Xinbai

10.12 Shenzhen Kexing

10.13 Jiangsu Wanbang

10.14 SPH NO.1 Biochemical & Pharma

10.15 Bioton S.A

11 Antidiabetics Manufacturing Cost Analysis

11.1 Antidiabetics Key Raw Materials Analysis

11.1.1 Key Raw Materials

11.1.2 Price Trend of Key Raw Materials

11.1.3 Key Suppliers of Raw Materials

11.1.4 Market Concentration Rate of Raw Materials

11.2 Proportion of Manufacturing Cost Structure

11.2.1 Raw Materials

11.2.2 Labor Cost

11.2.3 Manufacturing Expenses

11.3 Manufacturing Process Analysis of Antidiabetics

12 Industrial Chain, Sourcing Strategy and Downstream Buyers

12.1 Antidiabetics Industrial Chain Analysis

12.2 Upstream Raw Materials Sourcing

12.3 Raw Materials Sources of Antidiabetics Major Manufacturers in 2015

12.4 Downstream Buyers

13 Marketing Strategy Analysis, Distributors/Traders

13.1 Marketing Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Development Trend

13.2 Market Positioning

13.2.1 Pricing Strategy

13.2.2 Brand Strategy

13.2.3 Target Client

13.3 Distributors/Traders List

14 Europe Antidiabetics Market Forecast (2016-2021)

14.1 Germany Antidiabetics Sales Forecast (2016-2021)

14.2 France Antidiabetics Sales Forecast (2016-2021)

14.3 UK Antidiabetics Sales Forecast (2016-2021)

14.4 Russia Antidiabetics Sales Forecast (2016-2021)

14.5 Italy Antidiabetics Sales Forecast (2016-2021)

14.6 Spain Antidiabetics Sales Forecast (2016-2021)

14.7 Benelux Antidiabetics Sales Forecast (2016-2021)

14.8 Europe Antidiabetics Sales Forecast by Type (2016-2021)

14.9 Europe Antidiabetics Sales Forecast by Application (2016-2021)

15 Research Findings and Conclusion

16 Appendix

Methodology

Analyst Introduction

Data Source

Figure Picture of Antidiabetics

Table Classification of Antidiabetics

Figure Europe Sales Market Share of Antidiabetics by Type in 2015

Figure Biguanides Picture

Figure Thiazolodinediones Picture

Figure GLP-agonists Picture

Figure Sulphonylureas Picture

Figure DPP-4 inhibitors Picture

Figure SGLT-2 Picture

Figure Alpha-glucosidase Inhibitors Picture

Figure Meglitinides Picture

Table Application of Antidiabetics

Figure Europe Sales Market Share of Antidiabetics by Application in 2015

Figure Hospitals & Clinics Examples

Figure Retail pharmacies Examples

Figure Online sales Examples

Figure Germany Antidiabetics Revenue and Growth Rate (2011-2021)

Figure France Antidiabetics Revenue and Growth Rate (2011-2021)

Figure UK Antidiabetics Revenue and Growth Rate (2011-2021)

Figure Russia Antidiabetics Revenue and Growth Rate (2011-2021)

Figure Italy Antidiabetics Revenue and Growth Rate (2011-2021)

Figure Spain Antidiabetics Revenue and Growth Rate (2011-2021)

Figure Benelux Antidiabetics Revenue and Growth Rate (2011-2021)

Figure Europe Antidiabetics Sales and Growth Rate (2011-2021)

Figure Europe Antidiabetics Revenue and Growth Rate (2011-2021)

Table Europe Antidiabetics Sales of Key Manufacturers (2015 and 2016)

Table Europe Antidiabetics Sales Share by Manufacturers (2015 and 2016)

Figure 2015 Antidiabetics Sales Share by Manufacturers

Figure 2016 Antidiabetics Sales Share by Manufacturers

Table Europe Antidiabetics Revenue by Manufacturers (2015 and 2016)

Table Europe Antidiabetics Revenue Share by Manufacturers (2015 and 2016)

Table 2015 Europe Antidiabetics Revenue Share by Manufacturers

Table 2016 Europe Antidiabetics Revenue Share by Manufacturers

Table Europe Antidiabetics Sales and Market Share by Type (2011-2016)

Table Europe Antidiabetics Sales Share by Type (2011-2016)

Figure Sales Market Share of Antidiabetics by Type (2011-2016)

Figure Europe Antidiabetics Sales Growth Rate by Type (2011-2016)

Table Europe Antidiabetics Revenue and Market Share by Type (2011-2016)

Table Europe Antidiabetics Revenue Share by Type (2011-2016)

Figure Revenue Market Share of Antidiabetics by Type (2011-2016)

Figure Europe Antidiabetics Revenue Growth Rate by Type (2011-2016)

Table Europe Antidiabetics Sales and Market Share by Countries (2011-2016)

Table Europe Antidiabetics Sales Share by Countries (2011-2016)

Figure Sales Market Share of Antidiabetics by Countries (2011-2016)

Table Europe Antidiabetics Revenue and Market Share by Countries (2011-2016)

Table Europe Antidiabetics Revenue Share by Countries (2011-2016)

Figure Revenue Market Share of Antidiabetics by Countries (2011-2016)

Table Europe Antidiabetics Sales and Market Share by Application (2011-2016)

Table Europe Antidiabetics Sales Share by Application (2011-2016)

Figure Sales Market Share of Antidiabetics by Application (2011-2016)

Figure Germany Antidiabetics Sales and Growth Rate (2011-2016)

Figure Germany Antidiabetics Revenue and Growth Rate (2011-2016)

Figure Germany Antidiabetics Sales Price Trend (2011-2016)

Table Germany Antidiabetics Sales by Manufacturers (2015 and 2016)

Table Germany Antidiabetics Market Share by Manufacturers (2015 and 2016)

Table Germany Antidiabetics Sales by Type (2015 and 2016)

Table Germany Antidiabetics Market Share by Type (2015 and 2016)

Table Germany Antidiabetics Sales by Application (2015 and 2016)

Table Germany Antidiabetics Market Share by Application (2015 and 2016)

Figure France Antidiabetics Sales and Growth Rate (2011-2016)

Figure France Antidiabetics Revenue and Growth Rate (2011-2016)

Figure France Antidiabetics Sales Price Trend (2011-2016)

Table France Antidiabetics Sales by Manufacturers (2015 and 2016)

Table France Antidiabetics Market Share by Manufacturers (2015 and 2016)

Table France Antidiabetics Sales by Type (2015 and 2016)

Table France Antidiabetics Market Share by Type (2015 and 2016)

Table France Antidiabetics Sales by Application (2015 and 2016)

Table France Antidiabetics Market Share by Application (2015 and 2016)

Figure UK Antidiabetics Sales and Growth Rate (2011-2016)

Figure UK Antidiabetics Revenue and Growth Rate (2011-2016)

Figure UK Antidiabetics Sales Price Trend (2011-2016)

Table UK Antidiabetics Sales by Manufacturers (2015 and 2016)

Table UK Antidiabetics Market Share by Manufacturers (2015 and 2016)

Table UK Antidiabetics Sales by Type (2015 and 2016)

Table UK Antidiabetics Market Share by Type (2015 and 2016)

Table UK Antidiabetics Sales by Application (2015 and 2016)

Table UK Antidiabetics Market Share by Application (2015 and 2016)

Figure Russia Antidiabetics Sales and Growth Rate (2011-2016)

Figure Russia Antidiabetics Revenue and Growth Rate (2011-2016)

Figure Russia Antidiabetics Sales Price Trend (2011-2016)

Table Russia Antidiabetics Sales by Manufacturers (2015 and 2016)

Table Russia Antidiabetics Market Share by Manufacturers (2015 and 2016)

Table Russia Antidiabetics Sales by Type (2015 and 2016)

Table Russia Antidiabetics Market Share by Type (2015 and 2016)

Table Russia Antidiabetics Sales by Application (2015 and 2016)

Table Russia Antidiabetics Market Share by Application (2015 and 2016)

Figure Italy Antidiabetics Sales and Growth Rate (2011-2016)

Figure Italy Antidiabetics Revenue and Growth Rate (2011-2016)

Figure Italy Antidiabetics Sales Price Trend (2011-2016)

Table Italy Antidiabetics Sales by Manufacturers (2015 and 2016)

Table Italy Antidiabetics Market Share by Manufacturers (2015 and 2016)

Table Italy Antidiabetics Sales by Type (2015 and 2016)

Table Italy Antidiabetics Market Share by Type (2015 and 2016)

Table Italy Antidiabetics Sales by Application (2015 and 2016)

Table Italy Antidiabetics Market Share by Application (2015 and 2016)

Figure Spain Antidiabetics Sales and Growth Rate (2011-2016)

Figure Spain Antidiabetics Revenue and Growth Rate (2011-2016)

Figure Spain Antidiabetics Sales Price Trend (2011-2016)

Table Spain Antidiabetics Sales by Manufacturers (2015 and 2016)

Table Spain Antidiabetics Market Share by Manufacturers (2015 and 2016)

Table Spain Antidiabetics Sales by Type (2015 and 2016)

Table Spain Antidiabetics Market Share by Type (2015 and 2016)

Table Spain Antidiabetics Sales by Application (2015 and 2016)

Table Spain Antidiabetics Market Share by Application (2015 and 2016)

Figure Benelux Antidiabetics Sales and Growth Rate (2011-2016)

Figure Benelux Antidiabetics Revenue and Growth Rate (2011-2016)

Figure Benelux Antidiabetics Sales Price Trend (2011-2016)

Table Benelux Antidiabetics Sales by Manufacturers (2015 and 2016)

Table Benelux Antidiabetics Market Share by Manufacturers (2015 and 2016)

Table Benelux Antidiabetics Sales by Type (2015 and 2016)

Table Benelux Antidiabetics Market Share by Type (2015 and 2016)

Table Benelux Antidiabetics Sales by Application (2015 and 2016)

Table Benelux Antidiabetics Market Share by Application (2015 and 2016)

Table Antidiabetics Basic Information List

Table Sanofi-Aventis Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)

Figure Sanofi-Aventis Antidiabetics Sales Market Share (2011-2016)

Table Eli Lilly Basic Information List

Table Eli Lilly Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Eli Lilly Antidiabetics Sales Market Share (2011-2016)

Table Oramed Pharmaceuticals Basic Information List

Table Oramed Pharmaceuticals Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Oramed Pharmaceuticals Antidiabetics Sales Market Share (2011-2016)

Table Boehringer Ingelheim Basic Information List

Table Boehringer Ingelheim Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Boehringer Ingelheim Antidiabetics Sales Market Share (2011-2016)

Table Merck & Co. Inc Basic Information List

Table Merck & Co. Inc Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Merck & Co. Inc Antidiabetics Sales Market Share (2011-2016)

Table Bristol-Myers Squibb Basic Information List

Table Bristol-Myers Squibb Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Bristol-Myers Squibb Antidiabetics Sales Market Share (2011-2016)

Table Novo Nordisk Basic Information List

Table Novo Nordisk Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Novo Nordisk Antidiabetics Sales Market Share (2011-2016)

Table Halozyme Therapeutics Basic Information List

Table Halozyme Therapeutics Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Halozyme Therapeutics Antidiabetics Sales Market Share (2011-2016)

Table Pfizer Basic Information List

Table Pfizer Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Pfizer Antidiabetics Sales Market Share (2011-2016)

Table Takeda Pharmaceuticals Basic Information List

Table Takeda Pharmaceuticals Antidiabetics Sales, Revenue, Price and Gross Margin (2011-2016)

Table Takeda Pharmaceuticals Antidiabetics Sales Market Share (2011-2016)

Table Nanjing Xinbai Basic Information List

Table Shenzhen Kexing Basic Information List

Table Jiangsu Wanbang Basic Information List

Table SPH NO.1 Biochemical & Pharma Basic Information List

Table Bioton S.A Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Antidiabetics

Figure Manufacturing Process Analysis of Antidiabetics

Figure Antidiabetics Industrial Chain Analysis

Table Raw Materials Sources of Antidiabetics Major Manufacturers in 2015

Table Major Buyers of Antidiabetics

Table Distributors/Traders List

Figure Germany Antidiabetics Sales and Growth Rate Forecast (2016-2021)

Figure Germany Antidiabetics Revenue and Growth Rate Forecast (2016-2021)

Figure France Antidiabetics Sales and Growth Rate Forecast (2016-2021)

Figure France Antidiabetics Revenue and Growth Rate Forecast (2016-2021)

Figure UK Antidiabetics Sales and Growth Rate Forecast (2016-2021)

Figure UK Antidiabetics Revenue and Growth Rate Forecast (2016-2021)

Figure Russia Antidiabetics Sales and Growth Rate Forecast (2016-2021)

Figure Russia Antidiabetics Revenue and Growth Rate Forecast (2016-2021)

Figure Italy Antidiabetics Sales and Growth Rate Forecast (2016-2021)

Figure Italy Antidiabetics Revenue and Growth Rate Forecast (2016-2021)

Figure Spain Antidiabetics Sales and Growth Rate Forecast (2016-2021)

Figure Spain Antidiabetics Revenue and Growth Rate Forecast (2016-2021)

Figure Benelux Antidiabetics Sales and Growth Rate Forecast (2016-2021)

Figure Benelux Antidiabetics Revenue and Growth Rate Forecast (2016-2021)

Table Europe Antidiabetics Sales Forecast by Type (2016-2021)

Table Europe Antidiabetics Sales Forecast by Application (2016-2021)